scispace - formally typeset
S

Sue C. Kaste

Researcher at St. Jude Children's Research Hospital

Publications -  293
Citations -  12192

Sue C. Kaste is an academic researcher from St. Jude Children's Research Hospital. The author has contributed to research in topics: Cancer & Population. The author has an hindex of 54, co-authored 285 publications receiving 10775 citations. Previous affiliations of Sue C. Kaste include RMIT University & University of Memphis.

Papers
More filters
Journal ArticleDOI

Radiomics Features Differentiate Between Normal and Tumoral High-Fdg Uptake.

TL;DR: A FDG-PET radiomics tissue classifier for differentiating FDGavid- normal tissues from tumor is introduced and accurate normal tissue segmentation and classification facilitates accurate identification ofFDGavid tissues and classification of those tissues as either tumor or normal tissue.
Journal ArticleDOI

Late toxicity and outcomes following radiation therapy for chest wall sarcomas in pediatric patients.

TL;DR: Acute and late radiation therapy-associated toxicities in pediatric chest wall sarcoma patients are modest and the degree of scoliosis following resection is a function of the extent of resection and of the number and location of ribs resected.
Journal ArticleDOI

Unique MRI Findings as an Early Predictor of Osteonecrosis in Pediatric Acute Lymphoblastic Leukemia

TL;DR: The MRI signal abnormalities described here appear to herald extensive oste onecrosis and precede the typical MRI findings of osteonecrosis previously reported in the literature.
Journal ArticleDOI

Experience and expertise regarding orthodontic management of childhood and adolescent cancer survivors

TL;DR: The data from this study suggest a tendency for more experienced practitioners to have treated survivors of childhood cancer, and a need for more information regarding dental complications of pediatric cancer treatment and for guidelines for the orthodontic treatment of these patients.
Journal ArticleDOI

Pediatric Hodgkin lymphoma survivors at negligible risk for significant bone mineral density deficits.

TL;DR: It is hypothesized that pediatric Hodgkin lymphoma survivors would have bone mineral density (BMD) deficits compared to their peers because of osteotoxic chemotherapy during the time of greatest BMD accretion.